RX-1 Rhythm Express Remote Cardiac Monitoring System

The RX-1 Rhythm Express Remote Cardiac Monitoring System is designed for continuous, ambulatory ECG recording using standard electrodes, featuring an embedded algorithm for arrhythmia detection, ECG compression, and noise removal, with automated or manual event data transmission via cellular modem to a server for physician review. This system facilitates non-real-time cardiac monitoring for patients with suspected or known cardiac conditions, providing ECG data for subsequent professional analysis without offering direct diagnostic statements or alarms.

The RX-1 Rhythm Express Remote Cardiac Monitoring System is intended for patients weighing over 10 kg who have, or are at risk of, cardiac disease, or exhibit intermittent symptoms requiring continuous cardiac monitoring. Worn by the patient for a physician-prescribed period, typically 1 day to 4 weeks, the device connects to standard ECG electrodes to continuously capture 2-channel ECGs. It can function in three modes: Mobile Cardiac Telemetry (MCT), Event Recorder (ER), and Wireless Holter (WH). An embedded algorithm processes the acquired ECG to detect arrhythmias, compress the data, and remove most in-band noise without distorting ECG morphology. Upon detection of a cardiac event by the ECG analysis algorithm, or when manually initiated by the patient, the RX-1 system automatically transmits the recorded cardiac activity to a server via an integrated cellular modem. This data is then presented for review by a medical professional. The system communicates events from the patient to the monitoring center within one to seven minutes, assuming cell service availability, and is therefore not suitable for real-time arrhythmia event monitoring. The device does not sound alarms, deliver therapy, administer drugs, provide interpretive or diagnostic statements, or offer life support. Data received from the RX-1 can be used by other devices for arrhythmia analysis, reporting, and signal measurements.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What are the specific performance metrics (e.g., sensitivity, specificity, positive predictive value) of the embedded ECG analysis algorithm for detecting various types of arrhythmias?; How does the device's noise removal algorithm distinguish between physiological ECG signals and in-band noise, and what is its impact on ECG morphology integrity?; What are the data security and privacy measures implemented for the transmission and storage of patient ECG data via the cellular modem and RS-1 Web Service?; Can the system differentiate or prioritize events based on clinical severity before transmission to the server?; What is the typical battery life of the device under continuous use in each of its operational modes (MCT, ER, WH), and how does cellular signal strength affect power consumption?